In the current study, we reveal that nuclear C3b acts as a cofactor of the chromatin remodeling SIN3A complex to repress the expression of GADD45A, thus conferring acquired resistance of lung cancer to PTX treatment. The gene discussed is SIN3A; the disease is lung carcinoma.